Published in

Elsevier, Breast Diseases, 4(24), p. 384-385, 2013

DOI: 10.1016/j.breastdis.2013.10.007

Elsevier, European Journal of Cancer, 10(49), p. 2294-2302

DOI: 10.1016/j.ejca.2013.02.031

Links

Tools

Export citation

Search in Google Scholar

Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial

Journal article published in 2013 by R. W. Blamey, M. C. Stauder, T. Bates, U. Chetty, S. W. Duffy, I. O. Ellis, D. George, E. Mallon, M. J. Mitchell, I. Monypenny, D. A. L. Morgan ORCID, R. D. Macmillan, J. Patnick, S. E. Pinder
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Background. The incidence of local recurrence (LR) after conservative surgery for early breast cancer without adjuvant therapy is unacceptably high even with favourable tumours. The aim of this study was to examine the effect of adjuvant therapies in tumours with excellent prognostic features. Methods. Patients with primary invasive breast cancer